Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

ACRX

AcelRX Pharmaceuticals (ACRX)

AcelRX Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ACRX
DateTimeSourceHeadlineSymbolCompany
03/08/20184:01PMPR Newswire (US)AcelRx announces receipt of Type A FDA meeting minutes and plans to resubmit the DSUVIA New Drug Application in Q2 2018NASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/05/20187:00AMPR Newswire (US)AcelRx Pharmaceuticals to Participate at Three Upcoming Investor Events in MarchNASDAQ:ACRXAcelRX Pharmaceuticals Inc
03/02/20187:00AMPR Newswire (US)AcelRx Pharmaceuticals to Hold Annual 2017 Financial Results Conference Call and Webcast on Thursday, March 8th, 2018NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/16/20187:00AMPR Newswire (US)AcelRx Pharmaceuticals to Present at 2018 RBC Capital Markets Global Healthcare ConferenceNASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/14/20183:40PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
02/01/20188:45AMInvestorWirePromising New Approaches in Pain ManagementNASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/19/20175:21PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/19/20175:01PMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/04/20177:55AMGlobeNewswire Inc.Factors of Influence in 2018, Key Indicators and Opportunity within International Flavors & Fragrances, Harris, AcelRx Pharma...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
12/04/20177:02AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/30/201711:25AMEdgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/16/20177:00AMPR Newswire (US)AcelRx Pharmaceuticals Reports Publication of Manuscript Analyzing Sufentanil Sublingual Tablets in Patients with Postoperati...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/15/20177:02AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/14/20177:02AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/09/20174:21PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/09/20174:01PMPR Newswire (US)AcelRx Pharmaceuticals Reports Third Quarter 2017 Financial ResultsNASDAQ:ACRXAcelRX Pharmaceuticals Inc
11/09/20177:00AMPR Newswire (US)AcelRx Pharmaceuticals Reports Publication of Manuscript Evaluating Sufentanil Sublingual Tablets for Moderate-to-Severe Acut...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/30/20177:00PMPR Newswire (US)AcelRx Pharmaceuticals to Hold Third Quarter 2017 Financial Results Conference Call and Webcast on Thursday, November 9thNASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/20/20178:00AMPR Newswire (US)AcelRx's DSUVIA™ Clinical Trial Results Selected as a "Top Abstract" for Oral Presentation at ASA's Annual Meeting - ANESTH...NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/20/20177:02AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/12/20177:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/12/20176:45AMPR Newswire (US)AcelRx Pharmaceuticals Receives Complete Response Letter from the FDA for DSUVIA™ NDANASDAQ:ACRXAcelRX Pharmaceuticals Inc
10/03/20174:40PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/27/20174:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/11/20175:37PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
09/06/20174:30PMPR Newswire (US)AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in SeptemberNASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/24/20176:15PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/24/20175:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/23/20174:32PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
08/23/20176:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ACRXAcelRX Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ACRX

Your Recent History

Delayed Upgrade Clock